As multiple myeloid populations within the TME express the ligand CXCL9, including both DCs and tumor-associated macrophages (TAMs), and these chemokines are broadly induced in response to treatment, it remains another avenue to investigate in the maintenance of TSL within TLSs (79–82). The gene discussed is CXCL9; the disease is neoplasm.